FOLD
Amicus Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.56 / 10
Netural
Fund flow evaluation: 7.05/10 reflecting robust fund flow characteristics. Constructive Small and Medium trends face headwinds from adverse overall, block, Large, and Extra-large developments, indicating positive money flow direction. Analyst perspective reveals divided analyst consensus with neutral perspective.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-22
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for FOLD?
- FOLD holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.56/10 (Netural).
